Evidence map›Paper›PMID 36338358›Full record

ReviewJACC. Asia2021

Physiology-Based Revascularization: A New Approach to Plan and Optimize Percutaneous Coronary Intervention.

Joo Myung Lee, Seung Hun Lee, Doosup Shin, Ki Hong Choi, Tim P van de Hoef, Hyun Kuk Kim, Habib Samady, Tsunekazu Kakuta, Hitoshi Matsuo, Bon-Kwon Koo and 2 more

Registry-linked trialAbstract readReview
In one paragraph

Review in JACC. Asia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06376630 (Study of Microvascular Dysfunction, Coronary Flow Reserve and Cardioprotective Effect of Early Intravenously Administration of Esmolol in Patients With Myocardial Infarction), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06376630 narecruitingnot on this mapstarted 2024, after this paper: background citation

Study of Microvascular Dysfunction, Coronary Flow Reserve and Cardioprotective Effect of Early Intravenously Administration of Esmolol in Patients With Myocardial Infarction

TypeinterventionalSponsorNational Medical Research Center for Cardiology, Ministry of Health of Russian FederationRan2024 to 2030Enrolled300ConditionsMyocardial Infarction, Coronary Stenosis, Coronary Microvascular DysfunctionArmsEsmolol Hcl 10Mg/Ml Inj
3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Coronary Physiology to Guide Percutaneous Coronary Intervention: Why, When, and How.Journal of the Society for Cardiovascular Angiography & Interventions · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Joo Myung LeeDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Seung Hun LeeDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Doosup ShinDivision of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Ki Hong ChoiDivision of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Tim P van de HoefDepartment of Clinical and Experimental Cardiology, Amsterdam UMC-University of Amsterdam, Amsterdam, the Netherlands.
Hyun Kuk KimDepartment of Internal Medicine and Cardiovascular Center, Chosun University Hospital, University of Chosun College of Medicine, Gwangju, Republic of Korea.
Habib SamadyAndreas Gruentzig Cardiovascular Center, Emory University School of Medicine, Atlanta, Georgia, USA.
Tsunekazu KakutaDivision of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, Ibaraki, Japan.
Hitoshi MatsuoDepartment of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan.
Bon-Kwon KooDepartment of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea.
William F FearonDivision of Cardiovascular Medicine, Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
Javier EscanedHospital Clínico San Carlos, IDISSC, and Universidad Complutense de Madrid, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronary physiological assessment using fractional flow reserve or nonhyperemic pressure ratios has become a standard of care for patients with coronary atherosclerotic disease. However, most evidence has focused on the pre-interventional use of physiological assessment to aid revascularization decision-making, whereas post-interventional physiological assessment has not been well established. Although evidence for supporting the role of post-interventional physiological assessment to optimize immediate revascularization results and long-term prognosis has been reported, a more thorough understanding of these data is crucial in incorporating post-interventional physiological assessment into daily practice. Recent scientific efforts have also focused on the potential role of pre-interventional fractional flow reserve or nonhyperemic pressure ratio pullback tracings to characterize patterns of coronary atherosclerotic disease to better predict post-interventional physiological outcomes, and thereby identify the appropriate revascularization target. Pre-interventional pullback tracings with dedicated post-processing methods can provide characterization of focal versus diffuse disease or major gradient versus minor gradient stenosis, which would result in different post-interventional physiological results. This review provides a comprehensive look at the current evidence regarding the evolving role of physiological assessment as a functional optimization tool for the entire process of revascularization, and not merely as a pre-interventional tool for revascularization decision-making.

Indexed as

CI, confidence intervalDES, drug-eluting stent(s)FFR, fractional flow reservefractional flow reserveHR, hazard ratioiFR, instantaneous wave-free ratioinstantaneous wave-free ratioMACE, major adverse cardiac event(s)NHPR, nonhyperemic pressure rationonhyperemic pressure ratiosPCI, percutaneous coronary interventionpercutaneous coronary interventionprognosisTVF, target vessel failureVOCE, vessel-related composite event

Identifiers

PMID36338358
PMCPMC9627934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.